BioSpace News Archive

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the BD Veritor™ At-Home COVID-19 Test

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to potentially create new treatments that make a meaningful difference in patients’ lives, today announced financial results for the second quarter ended June 30, 2021.

Servier Pharmaceuticals, a growing leader in oncology committed to bringing the promise of tomorrow to the patients we serve, announced today that the U.S. Food and Drug Administration (FDA) approved TIBSOVO®.

Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2021 fourth quarter and full year ended June 30, 2021.

HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) has initiated a Phase Ib/II study of fruquintinib in combination with BeiGene’s tislelizumab in patients with advanced triple negative breast cancer (“TNBC”) or advanced endometrial cancer (“EC”) in the U.S. The first patient was dosed on August 24, 2021.

Rise in consumption of liquid nutritional supplements, increase in incidence of chronic diseases, and healthy aging & proactive consumption of nutritional interventions are anticipated to drive the global liquid dietary supplements market from 2021 to 2031.

The increasing adoption of capsule formulations in the rising geriatric population is bolstering the empty capsules market.

According to the report, the global surgical masks market was valued over US$ 15.6 Bn in 2020 and is projected to contract from 2021 to 2030.

According to the report, the global hip replacement implants market was valued at US$ 5 Bn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031.

Increase in usage of animal models in virology and infectious diseases, rise in adoption of CRISPR technology, and upsurge in likelihood of epidemic or pandemic outbreaks fuel the growth of the global animal model market.